KZA 0.00% 8.0¢ kazia therapeutics limited

San Antonio Breast Cancer Symposium 8 Dec, page-37

  1. 1,080 Posts.
    lightbulb Created with Sketch. 122
    Correction: Kazia is entering a phase 2 Agile trial sometime next year. If (and only if) the phase 2 is completed successfully the Phase 3 sequential trial can commence. Completion is expected in two to three years. This is specified in the "clinical trail summary" which can be found on the Kazia website and associated ASX announcement.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.